A robust method to study cancer heterogeneity in liquid biopsy
A new liquid biopsy method has been developed to detect cancer heterogeneity with high accuracy and reduced cost. The approach uses a streamlined protocol to profile single circulating tumor cells from a simple blood test, enabling genome-driven targeted therapy selection and monitoring of disease progression.